Celldex Therapeutics (CLDX) Interest Coverage Ratio (2010 - 2013)

Celldex Therapeutics (CLDX) recorded quarterly Interest Coverage Ratio of 260.16 in Q4 2013, up 85.47% quarter-over-quarter from 1789.92 in Q3 2013, and down 451.77% on a YoY basis from 73.96 in Q4 2012.

Celldex Therapeutics (CLDX) Interest Coverage Ratio (2010 - 2013) Analysis & Trends

Celldex Therapeutics' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 260.16 for Q4 2013.

  • In Q4 2013, Interest Coverage Ratio fell 451.77% year-over-year to 260.16; the TTM figure through Sep 2014 stood at 1323.46 (down 1980.82% YoY), while the FY2013 annual figure was 87.86, down 138.41% from the prior year.
  • Interest Coverage Ratio was 260.16 for Q4 2013 at Celldex Therapeutics, up from 1789.92 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 63.03 in Q4 2010 to a low of 1789.92 in Q3 2013.
  • Historically, Interest Coverage Ratio has averaged 158.68 across 4 years, with a median of 30.69 in 2012.
  • The sharpest annual moves came in 2011 and 2013: Interest Coverage Ratio grew 18.11% in 2011, then plunged 4523.15% in 2013.
  • A 4-year view of Interest Coverage Ratio shows it stood at 63.03 in 2010, then sank by 144.85% to 28.27 in 2011, then sank by 66.78% to 47.15 in 2012, then tumbled by 451.77% to 260.16 in 2013.
  • The last three Interest Coverage Ratio figures came in at 260.16 (Q4 2013), 1789.92 (Q3 2013), and 35.95 (Q2 2013), per Business Quant data.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 3.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 11.50
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -258.33
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 547.67
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 11.79
10 Celldex Therapeutics 2.16 Bn 2.16 Bn -1.44 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2013 -260.16
Sep 30, 2013 -1,789.92
Jun 30, 2013 -35.95
Mar 31, 2013 -56.13
Dec 31, 2012 -47.15
Sep 30, 2012 -38.72
Jun 30, 2012 -32.82
Mar 31, 2012 -30.69
Dec 31, 2011 -28.27
Sep 30, 2011 -26.21
Jun 30, 2011 -22.77
Mar 31, 2011 -19.91
Dec 31, 2010 63.03
Sep 30, 2010 -26.74
Jun 30, 2010 -27.80